Este marco puede utilizarse para generar fácilmente moléculas específicas capaces de "atacar" e inactivar un virus. La tecnología puede utilizarse para crear moléculas que se adapten fácilmente ...
Read moreAbilityPharma is currently completing an international Phase 2b clinical trial with its product ABTL0812 in patients with metastatic pancreatic cancer, a disease with a very low survival rate, with th...
Read moreEste hallazgo abre nuevas vías de investigación para determinar si las moléculas ITGA2 y MCAM tienen potencial como dianas terapéuticas. Serán necesarios nuevos estudios para determinar si la man...
Read moreThe paper, published in the scientific journal Gut Microbes, provides new insights into the metabolic connections that influence the relationship between diet and mental health.
Read moreThis alliance will drive research in pediatric cancer epigenetics, through access to IRB Barcelona's top-notch infrastructure, with the ultimate goal of translating this innovative knowledge into tang...
Read moreThe EU-funded CardioReGenix project focuses on technological innovations for the treatment of heart failure and myocardial ischemia. The goal is to overcome obstacles in cardiovascular disease (CVD) g...
Read moreThe European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.
Read moreIQS forma parte de APATDEGRAD, un proyecto que tiene como objetivo desarrollar y validar unos nuevos apósitos para reducir la inflamación de las úlceras de pie diabético, mediante una nueva tecnol...
Read moreA study led by the Digestive Diseases and Microbiota group at the Dr. Josep Trueta Biomedical Research Institute of Girona (IDIBGI) show a potential positive impact of traditional bread on patients wi...
Read moreA team from Institut de Recerca Sant Joan de Déu and IRB Barcelona has studied the cases of four children who have experienced two cancers during childhood and has addressed the origin of the second ...
Read moreLa modulación de los reguladores epigenéticos miR-376a-3p y miR-20a-5p puede contribuir a restablecer procesos biológicos relevantes para evitar la progresión de la enfermedad en pacientes con EC
Read moreUn grupo de investigación perteneciente al Instituto de Biomedicina de Sevilla (IBiS) ha descrito un mecanismo que se activa tras un infarto de miocardio y que implica a las proteínas Orai1, AC8 y C...
Read more